{"691068":{"#nid":"691068","#data":{"type":"news","title":"Institute for Bioengineering and Bioscience Announces New External Advisory Board Leadership and Members ","body":[{"value":"\u003Cdiv\u003E\u003Cp\u003EThe \u003Ca href=\u0022https:\/\/bioresearch.gatech.edu\/\u0022 rel=\u0022noreferrer noopener\u0022 target=\u0022_blank\u0022\u003EParker H. Petit Institute for Bioengineering and Bioscience\u003C\/a\u003E (IBB) is pleased to announce new leadership and membership for its \u003Ca href=\u0022https:\/\/bioresearch.gatech.edu\/about\/people\/advisory-board\u0022 rel=\u0022noreferrer noopener\u0022 target=\u0022_blank\u0022\u003EExternal Advisory Board\u003C\/a\u003E, which provides strategic guidance to help advance the institute\u0027s mission of accelerating interdisciplinary research and innovation.\u0026nbsp;\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv\u003E\u003Cp\u003EErin Dasher has been appointed chair of the External Advisory Board, and Vincent Ling will serve as vice chair. Dasher is founder and CEO of \u003Ca href=\u0022https:\/\/www.linkedin.com\/company\/glui-io\/\u0022 rel=\u0022noreferrer noopener\u0022 target=\u0022_blank\u0022\u003EGlui Inc.\u003C\/a\u003E, a global advertising company creating engagement experiences across digital platforms. A seasoned entrepreneur, investor, and attorney, she brings more than 25 years of experience in venture capital, private equity, and mergers and acquisitions. Ling is chief business officer at \u003Ca href=\u0022https:\/\/www.morphocell.com\/\u0022 rel=\u0022noreferrer noopener\u0022 target=\u0022_blank\u0022\u003EMorphocell Technologies\u003C\/a\u003E, where he leads commercialization of regenerative medicine technologies. He has more than 30 years of biotechnology leadership experience spanning cell therapies, protein engineering, and biopharmaceutical innovation.\u0026nbsp;\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv\u003E\u003Cp\u003EIBB extends its sincere appreciation to outgoing board chair Chris Gemmiti for his outstanding leadership and service to the institute. The institute also thanks Linda Griffith for her valued contributions as a member of the External Advisory Board. Their expertise and commitment have helped shape IBB\u0027s continued growth and impact.\u0026nbsp;\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv\u003E\u003Cp\u003EThe institute is also pleased to welcome six new members to the External Advisory Board:\u0026nbsp;\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv\u003E\u003Cul\u003E\u003Cli data-list-item-id=\u0022e72dedd6483cf827667bb2b4886fe7098\u0022\u003EChristopher Cashman, chief executive and advisor in the medical device, biologics, and advanced manufacturing sectors, with extensive leadership experience in public and private companies.\u0026nbsp;\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003Cdiv\u003E\u003Cul\u003E\u003Cli data-list-item-id=\u0022e9e41324bd99f6430583f947df7ec5102\u0022\u003ERachel Cassidy, senior go-to-market and ecosystem executive with more than 30 years of experience building global innovation partnerships across the technology industry.\u0026nbsp;\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003Cdiv\u003E\u003Cul\u003E\u003Cli data-list-item-id=\u0022ec11b998f2145affcc30e3e61c9178cea\u0022\u003EShawn P. Davis, CEO of \u003Ca href=\u0022https:\/\/www.liberatebio.com\/\u0022 rel=\u0022noreferrer noopener\u0022 target=\u0022_blank\u0022\u003ELiberate Bio\u003C\/a\u003E, where he leads the development of next-generation delivery technologies for genetic medicines and brings more than two decades of biotechnology and pharmaceutical leadership.\u0026nbsp;\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003Cdiv\u003E\u003Cul\u003E\u003Cli data-list-item-id=\u0022ed491b31155c6316632e305391c679866\u0022\u003ECharles A. Gersbach, director of the Duke Center for Advanced Genomic Technologies and the John W. Strohbehn Distinguished Professor of Biomedical Engineering at \u003Ca href=\u0022https:\/\/www.duke.edu\/\u0022 rel=\u0022noreferrer noopener\u0022 target=\u0022_blank\u0022\u003EDuke University\u003C\/a\u003E, internationally recognized for his work in genome editing and gene therapy.\u0026nbsp;\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003Cdiv\u003E\u003Cul\u003E\u003Cli data-list-item-id=\u0022ed1bf1c75dec04ba844fa62cd2b3aa163\u0022\u003ETodd McDevitt, vice president and head of Cell Therapy Research at \u003Ca href=\u0022https:\/\/www.gene.com\/\u0022 rel=\u0022noreferrer noopener\u0022 target=\u0022_blank\u0022\u003EGenentech\u003C\/a\u003E, who leads development of cell-based therapies and previously founded Georgia Tech\u0027s Stem Cell Engineering Center.\u0026nbsp;\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003Cdiv\u003E\u003Cul\u003E\u003Cli data-list-item-id=\u0022e0aec0ac2886d7c9ba45553a081356ea7\u0022\u003ERidhi Tariyal, co-founder and CEO of \u003Ca href=\u0022https:\/\/www.nextgenjane.com\/\u0022 rel=\u0022noreferrer noopener\u0022 target=\u0022_blank\u0022\u003ENextGen Jane\u003C\/a\u003E, whose work combines biotechnology, data science, and women\u0027s health to advance molecular understanding of uterine biology.\u0026nbsp;\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003Cdiv\u003E\u003Cp\u003E\u0022IBB is fortunate to have an exceptional group of leaders whose expertise spans biotechnology, medicine, entrepreneurship, engineering, and innovation,\u0022 said Andr\u00e9s Garc\u00eda, Regents\u2019 Professor in the\u202f\u003Ca href=\u0022https:\/\/www.me.gatech.edu\/\u0022 rel=\u0022noreferrer noopener\u0022 target=\u0022_blank\u0022\u003EGeorge W. Woodruff School of Mechanical Engineering\u003C\/a\u003E\u202fand\u202fIBB\u2019s Executive Director. \u0022We are grateful to our outgoing members for their dedicated service and look forward to working with our new leadership and board members as we continue to advance transformative bioengineering and bioscience research.\u0022\u0026nbsp;\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv\u003E\u003Cp\u003EThe External Advisory Board brings together leaders from industry, academia, and entrepreneurship to provide strategic guidance that supports IBB\u0027s research, education, commercialization, and partnerships.\u0026nbsp;\u003C\/p\u003E\u003C\/div\u003E","summary":"","format":"limited_html"}],"field_subtitle":"","field_summary":[{"value":"\u003Cp\u003EThe External Advisory Board brings together leaders from industry, academia, and entrepreneurship to provide strategic guidance that supports IBB\u0027s research, education, commercialization, and partnerships. Erin Dasher has been appointed chair of the External Advisory Board, and Vincent Ling will serve as vice chair. IBB extends its sincere appreciation to outgoing board chair Chris Gemmiti for his outstanding leadership and service to the institute. The institute also thanks Linda Griffith for her valued contributions as a member of the External Advisory Board.\u0026nbsp;\u003C\/p\u003E","format":"limited_html"}],"field_summary_sentence":[{"value":"IBB is pleased to announce new leadership and membership for its EAB, which provides strategic guidance to help advance the institute\u0027s mission of accelerating interdisciplinary research and innovation. "}],"uid":"36479","created_gmt":"2026-07-09 15:33:18","changed_gmt":"2026-07-09 15:40:32","author":"abowman41","boilerplate_text":"","field_publication":"","field_article_url":"","location":"Atlanta, GA","dateline":{"date":"2026-07-09T00:00:00-04:00","iso_date":"2026-07-09T00:00:00-04:00","tz":"America\/New_York"},"extras":[],"hg_media":{"680582":{"id":"680582","type":"image","title":"cropped_IBB-Ramblin-Wreck.jpg","body":"\u003Cp\u003EThe Ramblin Wreck drives past the Petit Biotechnology Building, home of the Parker H. Petit Institute for Bioengineering and Bioscience.\u003C\/p\u003E","created":"1783611550","gmt_created":"2026-07-09 15:39:10","changed":"1783611550","gmt_changed":"2026-07-09 15:39:10","alt":"The Ramblin Wreck drives past the Petit Biotechnology Building, a red brick building with large trees in the foreground.","file":{"fid":"264860","name":"_0000_IBB---Ramblin-Wreck.jpg","image_path":"\/sites\/default\/files\/2026\/07\/09\/_0000_IBB---Ramblin-Wreck.jpg","image_full_path":"http:\/\/hg.gatech.edu\/\/sites\/default\/files\/2026\/07\/09\/_0000_IBB---Ramblin-Wreck.jpg","mime":"image\/jpeg","size":256205,"path_740":"http:\/\/hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/2026\/07\/09\/_0000_IBB---Ramblin-Wreck.jpg?itok=xf6agjcf"}}},"media_ids":["680582"],"groups":[{"id":"1292","name":"Parker H. Petit Institute for Bioengineering and Bioscience (IBB)"}],"categories":[{"id":"138","name":"Biotechnology, Health, Bioengineering, Genetics"}],"keywords":[],"core_research_areas":[{"id":"39441","name":"Bioengineering and Bioscience"}],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cp\u003EAshlie Bowman | Communications Manager\u003C\/p\u003E\u003Cp\u003EParker H. Petit Institute for Bioengineering and Bioscience\u003C\/p\u003E","format":"limited_html"}],"email":[],"slides":[],"orientation":[],"userdata":""}}}